Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pregnancy and contraceptive use among women participating in an HIV prevention trial in Tanzania.

Odutola A, Baisley K, Hayes RJ, Rusizoka M, Tanton C, Weiss HA, Changalucha J, Ross DA, Watson-Jones D.

Sex Transm Infect. 2012 Oct;88(6):436-43. Epub 2012 Mar 21.

2.

A qualitative study of participant adherence in a randomized controlled trial of herpes suppressive therapy for HIV prevention in Tanzania.

Plummer ML, Watson-Jones D, Lees S, Baisley K, Matari S, Changalucha J, Clayton T, Mugeye K, Tanton C, Weiss HA, Ross DA, Hayes RJ.

AIDS Care. 2010 Apr;22(4):499-508. doi: 10.1080/09540120903202889.

PMID:
20140794
3.

Successful increase in contraceptive uptake among Kenyan HIV-1-serodiscordant couples enrolled in an HIV-1 prevention trial.

Ngure K, Heffron R, Mugo N, Irungu E, Celum C, Baeten JM.

AIDS. 2009 Nov;23 Suppl 1:S89-95. doi: 10.1097/01.aids.0000363781.50580.03.

4.

Pregnancy and contraceptive use among women participating in the FEM-PrEP trial.

Callahan R, Nanda K, Kapiga S, Malahleha M, Mandala J, Ogada T, Van Damme L, Taylor D; FEM-PrEP Study Group.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):196-203. doi: 10.1097/QAI.0000000000000413.

PMID:
25590272
5.

Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania.

Watson-Jones D, Baisley K, Rusizoka M, Tanton C, Mugeye K, Weiss HA, Changalucha J, Clayton T, Hambleton I, Ross DA, Hayes RJ.

Contemp Clin Trials. 2009 Nov;30(6):504-12. doi: 10.1016/j.cct.2009.07.002. Epub 2009 Aug 7.

PMID:
19665587
6.

School-based interventions for preventing HIV, sexually transmitted infections, and pregnancy in adolescents.

Mason-Jones AJ, Sinclair D, Mathews C, Kagee A, Hillman A, Lombard C.

Cochrane Database Syst Rev. 2016 Nov 8;11:CD006417. Review.

7.

Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania.

Watson-Jones D, Baisley K, Weiss HA, Tanton C, Changalucha J, Everett D, Chirwa T, Ross D, Clayton T, Hayes R.

AIDS. 2009 Jan 28;23(3):415-22. doi: 10.1097/QAD.0b013e32831ef523.

8.

[Current status of the female condom in Africa].

Deniaud F.

Sante. 1997 Nov-Dec;7(6):405-15. Review. French.

9.

Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.

Grabowski MK, Gray RH, Makumbi F, Kagaayi J, Redd AD, Kigozi G, Reynolds SJ, Nalugoda F, Lutalo T, Wawer MJ, Serwadda D, Quinn TC, Tobian AAR.

Lancet Glob Health. 2015 Aug;3(8):e478-e486. doi: 10.1016/S2214-109X(15)00086-8. Epub 2015 Jun 17.

10.

Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study.

Patel RC, Onono M, Gandhi M, Blat C, Hagey J, Shade SB, Vittinghoff E, Bukusi EA, Newmann SJ, Cohen CR.

Lancet HIV. 2015 Nov;2(11):e474-82. doi: 10.1016/S2352-3018(15)00184-8. Epub 2015 Oct 22. Review.

11.

Barrier contraceptive use and HIV infection among high-risk women in Cameroon.

Zekeng L, Feldblum PJ, Oliver RM, Kaptue L.

AIDS. 1993 May;7(5):725-31.

PMID:
8391273
12.

Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?

Ssali A, Namukwaya S, Bufumbo L, Seeley J, G Lalloo D, Kamali A, Parkes-Ratanshi R.

PLoS One. 2013 Sep 10;8(9):e73556. doi: 10.1371/journal.pone.0073556. eCollection 2013.

13.

Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial.

Sibeko S, Baxter C, Yende N, Karim QA, Karim SS.

Obstet Gynecol. 2011 Oct;118(4):895-904. doi: 10.1097/AOG.0b013e31822be512.

14.

Behavioral interventions for improving contraceptive use among women living with HIV.

Lopez LM, Grey TW, Chen M, Denison J, Stuart G.

Cochrane Database Syst Rev. 2016 Aug 9;(8):CD010243. doi: 10.1002/14651858.CD010243.pub3. Review.

PMID:
27505053
15.

Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.

Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Ortiz A, Fuchs J, Buchbinder S, Koblin B, Zwerski S, Rose S, Wang J, Corey L; HPTN 039 Protocol Team.

Lancet. 2008 Jun 21;371(9630):2109-19. doi: 10.1016/S0140-6736(08)60920-4.

16.

Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.

Le Cleach L, Trinquart L, Do G, Maruani A, Lebrun-Vignes B, Ravaud P, Chosidow O.

Cochrane Database Syst Rev. 2014 Aug 3;(8):CD009036. doi: 10.1002/14651858.CD009036.pub2. Review.

PMID:
25086573
17.

A prospective study of contraceptive use among African women in HIV-1 serodiscordant partnerships.

Heffron R, Were E, Celum C, Mugo N, Ngure K, Kiarie J, Baeten JM; Partners in Prevention HSV/HIV Transmission Study Team.

Sex Transm Dis. 2010 Oct;37(10):621-8. doi: 10.1097/OLQ.0b013e3181e1a162.

PMID:
20601930
18.

The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania.

Kapiga SH, Lyamuya EF, Lwihula GK, Hunter DJ.

AIDS. 1998 Jan 1;12(1):75-84.

PMID:
9456257
19.

Contraceptive use in women enrolled into preventive HIV vaccine trials: experience from a phase I/II trial in East Africa.

Kibuuka H, Guwatudde D, Kimutai R, Maganga L, Maboko L, Watyema C, Sawe F, Shaffer D, Matsiko D, Millard M, Michael N, Wabwire-Mangen F, Robb M.

PLoS One. 2009;4(4):e5164. doi: 10.1371/journal.pone.0005164. Epub 2009 Apr 10.

20.

Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.

Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L, Abdool Karim SS, Chirenje ZM.

Contraception. 2016 Jan;93(1):25-31. doi: 10.1016/j.contraception.2015.10.010. Epub 2015 Oct 28.

Supplemental Content

Support Center